載入...
Lithium delays progression of amyotrophic lateral sclerosis
ALS is a devastating neurodegenerative disorder with no effective treatment. In the present study, we found that daily doses of lithium, leading to plasma levels ranging from 0.4 to 0.8 mEq/liter, delay disease progression in human patients affected by ALS. None of the patients treated with lithium...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
National Academy of Sciences
2008
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2538879/ https://ncbi.nlm.nih.gov/pubmed/18250315 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0708022105 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|